These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32376439)

  • 1. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats.
    Al-Ali AAA; Sandra L; Versweyveld D; Pijpers I; Dillen L; Vermeulen A; Snoeys J; Holm R; Nielsen CU
    Int J Pharm; 2020 Jun; 583():119399. PubMed ID: 32376439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin.
    Lee CK; Ki SH; Choi JS
    Biopharm Drug Dispos; 2011 May; 32(4):245-51. PubMed ID: 21506134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions.
    Nielsen RB; Larsen BS; Holm R; Pijpers I; Snoeys J; Nielsen UG; Tho I; Nielsen CU
    Int J Pharm; 2023 Jul; 642():123094. PubMed ID: 37263451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration.
    Matzneller P; Kussmann M; Eberl S; Maier-Salamon A; Jäger W; Bauer M; Langer O; Zeitlinger M; Poeppl W
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):599-606. PubMed ID: 29616423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hydroxyzine on the transport of etoposide in rat small intestine.
    Kan WM; Liu YT; Hsiao CL; Shieh CY; Kuo JH; Huang JD; Su SF
    Anticancer Drugs; 2001 Mar; 12(3):267-73. PubMed ID: 11290874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
    Wang Y; Wang S; Xu Y; Wang P; Li S; Liu L; Liu M; Jin X
    Int J Nanomedicine; 2020; 15():7601-7613. PubMed ID: 33116490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
    Zhang H; Yao M; Morrison RA; Chong S
    Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
    Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
    J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats.
    Al-Ali AAA; Quach JRC; Bundgaard C; Steffansen B; Holm R; Nielsen CU
    Int J Pharm; 2018 May; 543(1-2):352-360. PubMed ID: 29635055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on etoposide pharmacokinetics after intravenous and oral administration in rats.
    Piao YJ; Li X; Choi JS
    Eur J Drug Metab Pharmacokinet; 2008; 33(3):159-64. PubMed ID: 19007041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.
    Zhao G; Huang J; Xue K; Si L; Li G
    Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
    Choi JS; Choi I; Choi DH
    Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
    Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
    Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
    Kwon H; Lionberger RA; Yu LX
    Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs.
    Khalid N; Sarfraz M; Arafat M; Akhtar M; Löbenberg R; Ur Rehman N
    J Pharm Pharm Sci; 2018; 21(1):398-408. PubMed ID: 30365396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral etoposide and zosuquidar bioavailability in rats: Effect of co-administration and
    Nielsen RB; Holm R; Pijpers I; Snoeys J; Nielsen UG; Nielsen CU
    Int J Pharm X; 2021 Dec; 3():100089. PubMed ID: 34977557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors.
    Yang S; Gursoy RN; Lambert G; Benita S
    Pharm Res; 2004 Feb; 21(2):261-70. PubMed ID: 15032307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation.
    Akhtar N; Talegaonkar S; Khar RK; Jaggi M
    J Biomed Nanotechnol; 2013 Jul; 9(7):1216-29. PubMed ID: 23909136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.